- Home
- BAM vs WST Comparison
BAM vs WST Comparison
Compare BAM & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BAM
- WST
- Stock Information
- Founded
- BAM 2022
- WST 1923
- Country
- BAM Canada
- WST United States
- Employees
- BAM N/A
- WST N/A
- Industry
- BAM
- WST Medical/Dental Instruments
- Sector
- BAM
- WST Health Care
- Exchange
- BAM Nasdaq
- WST Nasdaq
- Market Cap
- BAM 24.7B
- WST 23.2B
- IPO Year
- BAM N/A
- WST N/A
- Fundamental
- Price
- BAM $53.80
- WST $325.09
- Analyst Decision
- BAM Buy
- WST Strong Buy
- Analyst Count
- BAM 13
- WST 5
- Target Price
- BAM $52.71
- WST $437.75
- AVG Volume (30 Days)
- BAM 866.3K
- WST 418.2K
- Earning Date
- BAM 02-05-2025
- WST 02-13-2025
- Dividend Yield
- BAM 2.83%
- WST 0.26%
- EPS Growth
- BAM N/A
- WST N/A
- EPS
- BAM 1.09
- WST 6.74
- Revenue
- BAM N/A
- WST $2,876,400,000.00
- Revenue This Year
- BAM N/A
- WST N/A
- Revenue Next Year
- BAM $17.49
- WST $6.22
- P/E Ratio
- BAM $49.30
- WST $48.27
- Revenue Growth
- BAM N/A
- WST N/A
- 52 Week Low
- BAM $37.19
- WST $265.00
- 52 Week High
- BAM $59.58
- WST $413.70
- Technical
- Relative Strength Index (RSI)
- BAM 38.90
- WST 52.55
- Support Level
- BAM $57.18
- WST $313.92
- Resistance Level
- BAM $58.97
- WST $338.00
- Average True Range (ATR)
- BAM 1.37
- WST 7.54
- MACD
- BAM -0.41
- WST 0.42
- Stochastic Oscillator
- BAM 1.11
- WST 46.39
About BAM Brookfield Asset Management Inc Limited Voting Shares
Brookfield Asset Management Ltd engages in providing alternative asset management services through an ownership interest in a alternative asset management business. It offers a range of alternative investment products to investors around the world including public and private pension plans, endowments and foundations, sovereign wealth funds, financial institutions, insurance companies, and private wealth investors.
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, U.S., and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.